Email ID
Password
Scrip   
Starpharma secures A$15.6 million for VivaGel programme
20 November 2009
Christopher Spillane

The Australian firm Starpharma has raised A$15.6 million ($14.5 million) to fund a clinical programme for its lead product, VivaGel, in bacterial vaginosis.

The private placement offered 30 million shares at A$0.52 each and was led by Orbis, an existing investor in the company. Starpharma's...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36